Day: 6 July 2023

United States Adopted Name (USAN) Council and International Nonproprietary Names (INN) Expert Committee Recognizes New Therapeutic Class by Granting “nibrozetone” as New Generic Name for EpicentRx’s Lead Small Molecule NLRP3 Inhibitor, RRx-001

-New USAN name, a shortening of its chemical name, signifies a novel therapeutic class -Novel generic name highlights the anti-inflammatory, anticancer, and antioxidant properties of RRx-001 and its potential to…